OTC : COCSF

Coca-Cola FEMSA, S.A.B. de C.V.

$10.35 USD

-$0.28 (-2.68%)

Volume
100
Average Volume
1.64K
Market Capitalization
$5.44B
P/E Ratio
16.46
Dividend Yield
4.18%
Price Target
Year High
$12.24
Year Low
$7.57
Day High
—
Day Low
—
Payout Ratio
$0.67
Current Ratio
$1.10
Source Headline
Coca-Cola FEMSA (COCSF) to Release Quarterly Earnings on Wednesday

Coca-Cola FEMSA (OTCMKTS:COCSF - Get Free Report) is projected to release its results before the market opens on Wednesday, April 29th. Analysts expect Coca-Cola FEMSA to post earnings of $0.1411 per share and revenue of $3.9203 billion for the quarter. Coca-Cola FEMSA Price Performance COCSF opened at $10.05 on Monday. Coca-Cola FEMSA has a one

defenseworld.net - 2026-04-27 05:02:57

Get COCSF Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

COCSF Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

COCSF Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2023-08-16 JP Morgan Maintain Neutral Neutral
2023-08-02 Goldman Sachs Maintain Neutral Neutral
2023-07-12 UBS Maintain Neutral Neutral
2023-06-06 HSBC Upgrade Hold Buy
2023-06-05 Barclays Maintain Overweight Overweight
2023-05-25 JP Morgan Maintain Neutral Neutral
2023-05-04 Goldman Sachs Maintain Neutral Neutral
2023-05-03 Goldman Sachs Maintain Neutral Neutral
2023-04-17 Barclays Maintain Overweight Overweight
2023-03-27 JP Morgan Maintain Neutral Neutral
2023-01-25 JP Morgan Maintain Neutral Neutral
2023-01-22 B of A Securities Upgrade Neutral Buy
2023-01-18 UBS Downgrade Buy Neutral
2022-12-18 Barclays Maintain Overweight Overweight
2022-10-25 Barclays Maintain Overweight Overweight
2022-07-26 Barclays Maintain Overweight Overweight
2022-05-02 Barclays Upgrade Equal Weight Overweight
2022-01-18 Goldman Sachs Downgrade Buy Neutral
2021-08-02 Barclays Maintain Equal Weight Equal Weight
2020-07-12 Barclays Downgrade Overweight Equal Weight
2020-01-21 Goldman Sachs Upgrade Neutral Buy
2020-01-06 Citigroup Upgrade Neutral Buy
2019-11-14 UBS Maintain Buy Buy
2019-02-28 Barclays Maintain Overweight Overweight
2018-08-23 JP Morgan Maintain Neutral Neutral
2018-07-29 Barclays Maintain Overweight Overweight
2018-04-10 Barclays Maintain Overweight Overweight
2017-11-16 Credit Suisse Downgrade Outperform Neutral
2016-10-13 Barclays Maintain Overweight Overweight
2016-09-13 Citigroup Upgrade Sell Neutral
2016-09-07 Credit Suisse Upgrade Neutral Outperform
2016-07-23 Citigroup Downgrade Neutral Sell
2016-06-02 JP Morgan Maintain Neutral Neutral
2016-03-06 Barclays Maintain Overweight Overweight
2016-01-14 Goldman Sachs Downgrade Buy Neutral
2016-01-10 Nomura Downgrade Neutral Reduce
2015-10-11 Barclays Maintain Overweight Overweight
2015-07-13 Barclays Upgrade Equal Weight Overweight
2015-06-16 Goldman Sachs Upgrade Neutral Buy
2015-04-29 HSBC Downgrade Overweight Hold
2015-04-20 JP Morgan Maintain Neutral Neutral
2015-04-07 JP Morgan Maintain Neutral Neutral
2015-03-16 Barclays Maintain Equal Weight Equal Weight
2015-01-23 JP Morgan Maintain Neutral Neutral
2014-11-24 Barclays Maintain Equal Weight Equal Weight
2014-10-28 JP Morgan Maintain Overweight Overweight
2014-10-02 JP Morgan Maintain Overweight Overweight
2014-09-17 UBS Downgrade Buy Neutral
2014-06-02 JP Morgan Maintain Neutral Neutral
2013-06-06 Citigroup Upgrade Sell Neutral
2013-01-09 JP Morgan Maintain Neutral Neutral
2012-12-13 Citigroup Downgrade Neutral Sell
2012-07-15 B of A Securities Downgrade Neutral Underperform